GlassScriptPhysician profile
Jose Tavarez
NPI 1396083630
$2,287.33
in general payments reported to CMS, 2019-2025
17 companies · $553 in 2025
The $553 reported for 2025 was more than what 95% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.66 · 2021: $41.46 · 2022: $411 · 2023: $687 · 2024: $583 · 2025: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,822.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $823.94 | 2022-2025 | Azstarys |
| Tris Pharma INC | $365.62 | 2022-2025 | Dyanavel Xr, Quillichew Er, Onyda Xr |
| Ironshore Pharmaceuticals INC. | $191.53 | 2022-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $186.26 | 2022-2025 | Gardasil 9, Vaxneuvance, M-M-R II |
| Supernus Pharmaceuticals, INC. | $147.47 | 2023-2025 | Qelbree, Qelbree |
| Sobi, INC | $115.75 | 2021-2023 | |
| Collegium Pharmaceutical, INC. | $109.07 | 2025 | Jornay Pm |
| Sanofi-Aventis U.S. LLC | $78.80 | 2024 | |
| Glaxosmithkline, LLC. | $66.94 | 2019-2025 | Bexsero, Rotarix, Pediarix |
| Cranial Technologies, INC | $53.95 | 2022-2023 | Doc Band |
| Sanofi Pasteur INC. | $34.66 | 2023-2024 | |
| Neos Therapeutics, LP | $26.11 | 2022 | |
| Verrica Pharmaceuticals INC. | $22.59 | 2025 | Ycanth |
| Genentech USA, INC. | $21.59 | 2021 | |
| Pfizer INC. | $15.40 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $13.86 | 2025 | Skyclarys |
| Phadia US INC. | $13.79 | 2023 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Tavarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.